Risk factors for colorectal cancer in Crohn's colitis: A case-control study

Inflammatory Bowel Diseases

Volumn 12, Issue 6, 2006, Pages 491-496

  Siegel, Corey A ^a,b   Sands, Bruce E ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Colitis; Colon cancer; Colonoscopy; Crohn's disease; Risk factors; Surveillance

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CHILD; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; COLITIS; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33745284606     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/00054725-200606000-00008     Document Type: Article

References (34)

1. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med. 1990;323:1228-1233.
2. Lennard-Jones JE, Melville DM, Morson BC, et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990;31:800-806.
3. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis: results from a surveillance program. Dig Dis Sci. 1989;34:1536-1541.
4. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356-1362.
5. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
6. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854-862.
7. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonie involvement. Lancet. 1990;336:357-359.
8. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1590-1592.
9. Richards ME, Rickert RR, Nance FC. Crohn's disease-associated carcinoma: a poorly recognized complication of inflammatory bowel disease. Ann Surg. 1989;209:764-773.
10. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-2729.
11. Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis: a population study in central Israel. Gastroenterology. 1988;94:870-877.
12. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
13. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:1643-1649.
14. Broome U, Lofberg R, Veress B, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22:1404-1408.
15. Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology. 1996;110:432-440.
16. Lashner BA, Heidenreich PA, Su GL, et al. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1989;97:255-259.
17. Lashner BA, Provencher KS, Seidner DL, et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology. 1997;112:29-32.
18. Pinczowski D, Ekbom A, Baron J, et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994;107:117-120.
19. Moody GA, Jayanthi V, Probert CS, et al. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol. 1996;8:1179-1183.
20. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14:145-153.
21. Velayos SV, Walsh JM, Terdiman JP. Effect of 5-aminosalicylate use on colon cancer and dysplasia risk in ulcerative colitis: a meta-analysis. Gastroenterology. 2004;126:A20.
22. Croog V, Itzkowitz S, Harpaz N, et al. The effect of mesalamine (5ASA) on progression to colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:A20.
23. Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001;134:89-95.
24. Pardi DS, Loftus EV Jr, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003;124:889-893.
25. Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology. 2001;120:820-826.
26. Greenstein AJ. Cancer in inflammatory bowel disease. Mt Sinai J Med. 2000;67:227-240.
27. Gillen CD, Andrews HA, Prior P, et al. Crohn's disease and colorectal cancer. Gut. 1994;35:651-655.
28. Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignancies in Crohn's disease: a 20-year experience. Dis Colon Rectum. 1990;33:7-11.
29. Murphy SN, Chueh HC. A security architecture for query tools used to access large biomedical databases. Proc AMIA Symp. 2002:552-556.
30. Delaunoit T, Limburg PJ, Goldberg RM, et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335-342.
31. Choi PM, Nugent FW, Schoetz DJ Jr, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418-424.
32. Hata K, Watanabe T, Kazama S, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer. 2003;89:1232-1236.
33. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711-714.
34. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol. 1990;85:1083-1087.